These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 33115835

  • 1. Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret.
    Barbeau DJ, Albe JR, Nambulli S, Tilston-Lunel NL, Hartman AL, Lakdawala SS, Klein E, Duprex WP, McElroy AK.
    mSphere; 2020 Oct 28; 5(5):. PubMed ID: 33115835
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rift Valley Fever Virus Encephalitis: Viral and Host Determinants of Pathogenesis.
    Wilson LR, McElroy AK.
    Annu Rev Virol; 2024 Sep 28; 11(1):309-325. PubMed ID: 38635867
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis.
    Harmon JR, Spengler JR, Coleman-McCray JD, Nichol ST, Spiropoulou CF, McElroy AK.
    J Virol; 2018 Dec 15; 92(24):. PubMed ID: 30258000
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neutrophil and macrophage influx into the central nervous system are inflammatory components of lethal Rift Valley fever encephalitis in rats.
    Albe JR, Boyles DA, Walters AW, Kujawa MR, McMillen CM, Reed DS, Hartman AL.
    PLoS Pathog; 2019 Jun 15; 15(6):e1007833. PubMed ID: 31220182
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K, Tercero BR, Makino S.
    Virus Res; 2016 May 02; 216():55-65. PubMed ID: 26022573
    [Abstract] [Full Text] [Related]

  • 15. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
    Scharton D, Bailey KW, Vest Z, Westover JB, Kumaki Y, Van Wettere A, Furuta Y, Gowen BB.
    Antiviral Res; 2014 Apr 02; 104():84-92. PubMed ID: 24486952
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Wichgers Schreur PJ, van Keulen L, Kant J, Kortekaas J.
    Vaccine; 2017 May 25; 35(23):3123-3128. PubMed ID: 28457675
    [Abstract] [Full Text] [Related]

  • 20. Intact Type I Interferon Receptor Signaling Prevents Hepatocellular Necrosis but Not Encephalitis in a Dose-Dependent Manner in Rift Valley Fever Virus Infected Mice.
    Michaely LM, Schuwerk L, Allnoch L, Schön K, Waltl I, Larsen PK, Pavlou A, Prajeeth CK, Rimmelzwaan GF, Becker SC, Kalinke U, Baumgärtner W, Gerhauser I.
    Int J Mol Sci; 2022 Oct 18; 23(20):. PubMed ID: 36293352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.